-
1
-
-
77953069934
-
Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients
-
Balocco, M., Carrara, P., Pinto, V. & Forni, G.L. (2010) Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients. American Journal of Hematology, 85, 460-461.
-
(2010)
American Journal of Hematology
, vol.85
, pp. 460-461
-
-
Balocco, M.1
Carrara, P.2
Pinto, V.3
Forni, G.L.4
-
2
-
-
33646414765
-
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia
-
Cappellini, M.D., Cohen, A., Piga, A., Bejaoui, M., Perrotta, S., Agaoglu, L., Aydinok, Y., Kattamis, A., Kilinc, Y., Porter, J., Capra, M., Galanello, R., Fattoum, S., Drelichman, G., Magnano, C., Verissimo, M., Athanassiou-Metaxa, M., Giardina, P., Kourakli-Symeonidis, A., Janka-Schaub, G., Coates, T., Vermylen, C., Olivieri, N., Thuret, I., Opitz, H., Ressayre-Djaffer, C., Marks, P. & Alberti, D. (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood, 107, 3455-3462.
-
(2006)
Blood
, vol.107
, pp. 3455-3462
-
-
Cappellini, M.D.1
Cohen, A.2
Piga, A.3
Bejaoui, M.4
Perrotta, S.5
Agaoglu, L.6
Aydinok, Y.7
Kattamis, A.8
Kilinc, Y.9
Porter, J.10
Capra, M.11
Galanello, R.12
Fattoum, S.13
Drelichman, G.14
Magnano, C.15
Verissimo, M.16
Athanassiou-Metaxa, M.17
Giardina, P.18
Kourakli-Symeonidis, A.19
Janka-Schaub, G.20
Coates, T.21
Vermylen, C.22
Olivieri, N.23
Thuret, I.24
Opitz, H.25
Ressayre-Djaffer, C.26
Marks, P.27
Alberti, D.28
more..
-
3
-
-
34548708556
-
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review
-
Delea, T.E., Edelsberg, J., Sofrygin, O., Thomas, S.K., Baladi, J.F., Phatak, P.D. & Coates, T.D. (2007) Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion, 47, 1919-1929.
-
(2007)
Transfusion
, vol.47
, pp. 1919-1929
-
-
Delea, T.E.1
Edelsberg, J.2
Sofrygin, O.3
Thomas, S.K.4
Baladi, J.F.5
Phatak, P.D.6
Coates, T.D.7
-
4
-
-
74049116227
-
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
-
Farmaki, K., Tzoumari, I., Pappa, C., Chouliaras, G. & Berdoukas, V. (2010) Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. British Journal of Haematology, 148, 466-475.
-
(2010)
British Journal of Haematology
, vol.148
, pp. 466-475
-
-
Farmaki, K.1
Tzoumari, I.2
Pappa, C.3
Chouliaras, G.4
Berdoukas, V.5
-
5
-
-
77955874679
-
Combined iron chelation therapy
-
Galanello, R., Agus, A., Campus, S., Danjou, F., Giardina, P.J. & Grady, R.W. (2010) Combined iron chelation therapy. Annals of the New York Academy of Sciences, 1202, 79-86.
-
(2010)
Annals of the New York Academy of Sciences
, vol.1202
, pp. 79-86
-
-
Galanello, R.1
Agus, A.2
Campus, S.3
Danjou, F.4
Giardina, P.J.5
Grady, R.W.6
-
6
-
-
77955891235
-
Retrospective study on the combination of desferrioxamine and deferasirox for treatment of iron-overloaded thalassemic patients: first evidence of more than 2years
-
Jetsrisuparb, A., Komvilaisak, P., Wiangnon, S. & Jetsrisuparb, C. (2010) Retrospective study on the combination of desferrioxamine and deferasirox for treatment of iron-overloaded thalassemic patients: first evidence of more than 2years. Journal of Pediatric Hematology Oncology, 32, 400-403.
-
(2010)
Journal of Pediatric Hematology Oncology
, vol.32
, pp. 400-403
-
-
Jetsrisuparb, A.1
Komvilaisak, P.2
Wiangnon, S.3
Jetsrisuparb, C.4
-
7
-
-
56149116825
-
Safety and efficacy of combined chelation therapy with deferasirox and deferoxamine in a gerbil model of iron overload
-
Otto-Duessel, M., Brewer, C., Gonzalez, I., Nick, H. & Wood, J.C. (2008) Safety and efficacy of combined chelation therapy with deferasirox and deferoxamine in a gerbil model of iron overload. Acta Haematologica, 120, 123-128.
-
(2008)
Acta Haematologica
, vol.120
, pp. 123-128
-
-
Otto-Duessel, M.1
Brewer, C.2
Gonzalez, I.3
Nick, H.4
Wood, J.C.5
-
8
-
-
84893487087
-
Oral deferiprone for iron chelation in people with thalassaemia
-
Roberts, D.J., Brunskill, S.J., Doree, C., Williams, S., Howard, J. & Hyde, C.J. (2007) Oral deferiprone for iron chelation in people with thalassaemia. Cochrane Database of Systematic Reviews, 18;(3): CD004839.
-
(2007)
Cochrane Database of Systematic Reviews
, vol.18
, Issue.3
-
-
Roberts, D.J.1
Brunskill, S.J.2
Doree, C.3
Williams, S.4
Howard, J.5
Hyde, C.J.6
-
9
-
-
44049102508
-
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
-
Tanner, M.A., Galanello, R., Dessi, C., Smith, G.C., Westwood, M.A., Agus, A., Pibiri, M., Nair, S.V., Walker, J.M. & Pennell, D.J. (2008) Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. Journal of Cardiovascular Magnetic Resonance, 10, 12.
-
(2008)
Journal of Cardiovascular Magnetic Resonance
, vol.10
, pp. 12
-
-
Tanner, M.A.1
Galanello, R.2
Dessi, C.3
Smith, G.C.4
Westwood, M.A.5
Agus, A.6
Pibiri, M.7
Nair, S.V.8
Walker, J.M.9
Pennell, D.J.10
-
10
-
-
4544301060
-
Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease
-
Voskaridou, E., Douskou, M., Terpos, E., Papassotiriou, I., Stamoulakatou, A., Ourailidis, A., Loutradi, A. & Loukopoulos, D. (2004) Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. British Journal of Haematology, 126, 736-742.
-
(2004)
British Journal of Haematology
, vol.126
, pp. 736-742
-
-
Voskaridou, E.1
Douskou, M.2
Terpos, E.3
Papassotiriou, I.4
Stamoulakatou, A.5
Ourailidis, A.6
Loutradi, A.7
Loukopoulos, D.8
|